COMPLETED

Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select courts in rural and urban communities in Ohio.

Official Title

Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Quick Facts

Study Start:2022-11-10
Study Completion:2025-09-29
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05493475

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * Not incarcerated at time of study enrollment
  3. * Currently enrolled in one of the following Ohio drug courts: Criminal drug court, Veterans' court, Mental health court, Human trafficking court, Family treatment court, O.V.I. court or on probation with a participating court
  4. * Self-reported use of illicit stimulants in the past 6 months
  5. * Has a phone number or email address to allow for follow-up contact
  6. * Understands English (Based on the 2012-2016 American Community Survey, only 2.4% of Ohioans 5 years and older speak English less than "very well.")
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Nichole Michaels, PhD
PRINCIPAL_INVESTIGATOR
Nationwide Children's Hospital, Center for Injury Research & Policy
Gary Smith, MD, DRPH
PRINCIPAL_INVESTIGATOR
Nationwide Children's Hospital, Center for Injury Research & Policy

Study Locations (Sites)

Nationwide Children's Hospital
Columbus, Ohio, 43207
United States

Collaborators and Investigators

Sponsor: Nationwide Children's Hospital

  • Nichole Michaels, PhD, PRINCIPAL_INVESTIGATOR, Nationwide Children's Hospital, Center for Injury Research & Policy
  • Gary Smith, MD, DRPH, PRINCIPAL_INVESTIGATOR, Nationwide Children's Hospital, Center for Injury Research & Policy

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-10
Study Completion Date2025-09-29

Study Record Updates

Study Start Date2022-11-10
Study Completion Date2025-09-29

Terms related to this study

Additional Relevant MeSH Terms

  • Opiate Overdose
  • Fentanyl Overdose
  • Harm Reduction